The Value of Contraception to Prevent Perinatal HIV Transmission

Overview

Journal Sex Transm Dis

Specialty Infectious Diseases

Date 2006 Mar 1

PMID 16505747

Citations 78

Authors

Heidi W Reynolds

Barbara Janowitz

Rick Homan

Laura Johnson

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to highlight the value of preventing unintended pregnancies among HIV-infected women as a strategy to prevent perinatal HIV transmission.

Goal: The goal of this study was to assess the cost-effectiveness of family planning programs to avert HIV-positive births with the current programmatic emphasis: prenatal care services that provide and promote nevirapine for prevention of mother-to-child transmission of HIV.

Study Design: Cost-effectiveness analyses were conducted from the health system perspective during 1 year with a hypothetical sub-Saharan African population. Expected program costs were combined with number of HIV-positive births averted for each strategy.

Results: At the same level of expenditure, the contraceptive strategy averts 28.6% more HIV-positive births than nevirapine for prevention of mother-to-child transmission of HIV.

Conclusions: Increasing contraceptive use among nonusers of contraception who do not want to get pregnant is cost-effective and is an equally important strategy to prevent perinatal transmission as prenatal care programs that provide and promote nevirapine to HIV-infected mothers.

Citing Articles

Cost-effectiveness of linking HIV and family planning services to prevent unintended pregnancies among women living with HIV.

Joshi B, Chaurasia H, R R, Shetty S, Kharat N, Begum S PLoS One. 2024; 19(12):e0314308.

PMID: 39636890 PMC: 11620344. DOI: 10.1371/journal.pone.0314308.

A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant.

Adeojo L, Patel R, Sambol N Pharmaceutics. 2024; 16(8).

PMID: 39204395 PMC: 11359785. DOI: 10.3390/pharmaceutics16081050.

The impacts of family planning and HIV service integration on contraceptive prevalence among HIV positive women in Tanzania: a comparative analysis from the 2016/17 Tanzania HIV impact survey.

Timoth S, Machange J, Karino K, Mtenga S, Mkopi A, Levira F Contracept Reprod Med. 2023; 8(1):58.

PMID: 38057924 PMC: 10698873. DOI: 10.1186/s40834-023-00260-w.

Contraceptive use and associated factors among women of reproductive age on antiretroviral therapy in Awabel Woreda health centers, Northwest Ethiopia.

Amsalu M, Worku K, Ayalew M, Alamneh A SAGE Open Med. 2023; 11:20503121231190275.

PMID: 38020801 PMC: 10640806. DOI: 10.1177/20503121231190275.

Incidence of unintended pregnancy and associated factors among adolescent girls and young women at risk of HIV infection in Kampala, Uganda.

Namukisa M, Kamacooko O, Lunkuse J, Ruzagira E, Price M, Mayanja Y Front Reprod Health. 2023; 5:1089104.

PMID: 36910339 PMC: 9995850. DOI: 10.3389/frph.2023.1089104.